The Mark Foundation for Cancer Research has awarded a $1 million grant to the NYGC to help investigate the genomic factors of cancer in ethnically diverse populations.
The advancement of sequencing technology has had the singe biggest effect on genomics research. As it develops further, so does the scope of genomic research and applications.
By identifying and characterizing specific types of mutations in individual cell lines, using a combination of whole genome sequencing and multi-omic approaches, researchers hope to improve stem cells’ therapeutic uses and potential.
The National Institute on Aging Genetics of Alzheimer’s Disease Data Storage Site (NIAGADS) will begin making large-scale DNA sequence data available to investigators.
US representatives are pressing genetic testing companies for details on their security systems and customer privacy policies.
The debate about the pros and cons of genetically screening embryos is deeply entrenched. Perhaps we should let couples decide?
Scientists have published one of the most detailed maps ever made of structural variations in a cancer cell’s genome.
There are very few reported cases of children inheriting almost all of their genes from a single parent, but this 11-year-old girl is the first one so far without any signs of cancer.
People living in England will be the first in the world to have access to DNA tests as routine care starting this fall, putting the NHS at the forefront of healthcare, as it takes a huge step towards precision medicine.
As the NHS celebrates its 70th birthday, Genomics England announces that it has now passed the 70,000 genomes mark.
The koala genome, published today, identifies powerful anti-bacterials in milk that protect the baby koala from disease – and may provide humans with the next generation of antibiotics.
By sequencing the genomes of other species, we can better understand our place in natural history.
Cancer Research UK Cambridge Institute is pushing for the use of genetic testing to transform treatment of breast cancer with the Personalised Breast Cancer Programme.